FDA Clears Imperative's Thrombectomy System for PE Treatment

Imperative Care announced FDA clearance of its Symphony Thrombectomy System to treat pulmonary embolism (PE).

This clearance expands the use of Symphony – previously for the treatment of venous thrombosis – to now include PE, providing a comprehensive solution to effectively and efficiently treat the full spectrum of venous thromboembolism (VTE) patient needs.

The clearance follows the successful completion of the SYMPHONY-PE Study, a pivotal Investigational Device Exemption (IDE) trial evaluating the safety and efficacy of Symphony for the treatment of acute PE.